 (Thorax 1995;50:777-781) 
Ten healthy adult volunteers with no past history of lung disease or symptoms suggesting viral infection in the last three months acted as controls.
The study was approved by the local ethical committee and all subjects gave written consent before taking part.
BRONCHOALVEOLAR LAVAGE (BAL)
A standardised BAL was performed on all subjects using an Olympus P20 fibreoptic bronchoscope. Following sedation with 5 mg intravenous midazolam the vocal cords were anaesthetised under direct vision with 4% lignocaine. Further lignocaine (2 ml aliquots of a 2% solution) was used in the airways as necessary as the bronchoscope was advanced. The tip of the bronchoscope was wedged in a subsegmental bronchus of the right middle lobe and a total of 180 ml of warmed, sterile 0 9% normal saline was instilled in 20 ml aliquots. The BAL fluid was aspirated under low pressure wall suction into a sterile, siliconised glass bottle kept on ice as recommended in the report of the European Society of Pneumology Task Group on BAL. ' HLA-DR expression was quantified on each preparation stained with monoclonal antibody RFDR1 by measurement of optical density using a monochrome video camera attached to a microscope with a x 40 objective. The relative density of the reaction product was recorded using a computerised image analyser (Seescan, Cambridge, UK). No counterstaining was used in this preparation. Optical density measured per unit area was directly proportional to the intensity of the staining.
The measurements were carried out on multiple cells randomly selected from at least six high power fields from each cytospin preparation including negative controls. The density of HLA-DR antigens was determined by the difference between the median optical density of a given sample and its negative control. The reading thus obtained was expressed on an arbitrary linear scale. To allow for day to day variation in measured optical density a cytospin preparation from one specific control was always stained and counted within every batch ofoptical density measurements. Thresholds were then adjusted each time to this standard preparation. Results between different batches could then be related to each other using the result of the specific constant control.
The relative proportions of macrophage subsets was determined using monoclonal antibodies RFD1 and RFD7 ( No difference was seen between the two groups in the relative proportions of macrophages expressing antigen presenting cell (RFD 1 + RFD7 -), phagocytic cell (RFD 1-RFD7 +), and suppressive cell (RFD1 + RFD7 +) phenotypes. Expressed as RFD1 +: RFD7 + :RFD1 +/RFD7 + the mean values were 28:50:22 and 20:56:24 for HIV positive subjects and controls, respectively (fig 1) .
Median HLA-DR expression on alveolar macrophages as measured by optical density readings was increased by 60% in the HIV positive group (p<0 005) (fig 2) . The distribution ofthis expression showed greater variation in the HIV positive group than in the controls. The overall range of expression by cells of the control group fell within that of the HIV positive group. Thus, only a proportion of HIV positive alveolar macrophages showed increased expression (fig 3) . SIGNIFICANCE 
